GeneFerm Biotechnology Co., Ltd. (TPEX:1796)
Taiwan · Delayed Price · Currency is TWD 28.80
-0.20 (-0.69%)
Oct 20, 2026, 1:30 PM CST
GeneFerm Biotechnology Market Cap
GeneFerm Biotechnology has a market cap or net worth of 1.19 billion as of October 20, 2026. It is the 32,531st most valuable company in the world and the 1,947th biggest in Taiwan. Its market cap has decreased by 42.86% in one year.
Market Cap
1.19B
Enterprise Value
1.22B
Revenue
664.94M
Global Rank
Country Rank
#1,947 Taiwan
PE Ratio
70.19
ChartMarket Cap Chart
Since July 26, 2016, GeneFerm Biotechnology's market cap has decreased from 2.17B to 1.19B, a decrease of -45.08%. That is a compound annual growth rate of -5.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 1.19B | -40.31% |
| Dec 31, 2025 | 2.00B | 2.66% |
| Dec 31, 2024 | 1.95B | -36.91% |
| Dec 29, 2023 | 3.09B | 11.36% |
| Dec 30, 2022 | 2.77B | 53.32% |
| Dec 30, 2021 | 1.81B | 122.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TSH Biopharm Corporation | 2.16B |
| Johnson Chemical Pharmaceutical Works | 2.13B |
| Tien Liang BioTech | 1.83B |
| InnoPharmax | 1.13B |
| Excelsior Biopharma | 1.11B |
| Anxo Pharmaceutical | 1.07B |
| Prince Pharmaceutical | 1.07B |
| DV Biomed | 874.13M |